Chronic Inflammation Pathway NF-κB Cooperates with Epigenetic Reprogramming to Drive the Malignant Progression of Glioblastoma

Without an effective strategy for targeted therapy, glioblastoma is still incurable with a median survival of only 15 months. Both chronic inflammation and epigenetic reprogramming are hallmarks of cancer. However, the mechanisms and consequences of their cooperation in glioblastoma remain unknown....

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Kefeng, Gao, Wenli, Chen, Ning, Yang, Shuyao, Wang, Han, Wang, Ran, Xie, Fang, Meng, Jiaqi, Lam, Eric W.-F., Li, Suyi, Cheng, Wei, Chen, Puxiang, Wu, Hongjin, Yan, Jinsong, Jin, Di, Jin, Bilian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576505/
https://www.ncbi.nlm.nih.gov/pubmed/36263173
http://dx.doi.org/10.7150/ijbs.73749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576505/
https://www.ncbi.nlm.nih.gov/pubmed/36263173
http://dx.doi.org/10.7150/ijbs.73749

Ejemplares similares